Director Dealing
Director Dealing
December 19, 2018
Download full announcement
The Company was informed that today, Christopher Mills, a non-executive director, completed the purchase of 5,970 ordinary shares of 0.25 pence each (“Ordinary Shares”) in the Company at a price of 103 pence per share.
Following this purchase, Mr Mills is interested in 9,196,400 Ordinary Shares representing 17.09% of the total voting rights in the Company.
| Renalytix AI plc | www.renalytixai.com | |
| James McCullough, CEO | Via Walbrook PR or Tel: +1 646 397 3970 |
|
| N+1 Singer (Nominated Adviser & Broker) | Tel: 020 7496 3000 | |
| Aubrey Powell / James White / George Tzimas (Corporate Finance) | ||
| Tom Salvesen / Mia Gardner (Corporate Broking) | ||
| Walbrook PR Limited | Tel: 020 7933 8780 renalytix@walbrookpr.com |
|
| Paul McManus Lianne Cawthorne |
Mob: 07980 541 893 / 07584 391 303 |
|